Researcher
Tom Decroo
Affiliations
- HIV and Tuberculosis (Research unit)
Member
From1 Oct 2021 → Today - Sexual Health including HIV (Research unit)
Member
From13 Oct 2015 → 29 Jun 2017 - HIV and Tuberculosis (Research unit)
Member
From1 Jul 2013 → 30 Sep 2021
Projects
1 - 10 of 13
- Drug resistant tuberculosis: optimize the composition of new treatment regimens in VietnamFrom1 Jan 2023 → Today
- Impact of diagnostic delays and short treatment regimens on outcomes of rifampicin-resistant tuberculosis patients in CameroonFrom1 Jan 2022 → Today
- TB/NTM Research ClusterFrom1 Jan 2022 → Today
- Nontuberculous mycobacteria pulmonary disease and tuberculosis-nontuberculous mycobacteria co-infection: Epidemiology, diagnosis, and management at a tertiary health facility in GhanaFrom1 Jan 2022 → Today
- Alternative methodological approaches to assess longterm HIV virological and clinical outcomes in resource limited settingsFrom27 Apr 2021 → Today
- Performance of community-based ART programmes for key populations in Nigeria and sub-Saharan AfricaFrom1 Jan 2021 → Today
- Accurate diagnosis and effective treatment for tuberculosis retreatment patients in NigerFrom1 Jan 2021 → Today
- Innovative diagnostic and therapeutic measures to improve MDR-TB diagnosis and management in Conakry, GuineaFrom1 Jan 2020 → Today
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?From1 Oct 2018 → Today
- Novel high-dose tuberclosis retreatment regimens: How to overcome resistance without creating more?From1 Oct 2018 → 30 Sep 2021
Publications
21 - 30 of 120
- Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century(2022)
Authors: Jean Claude Semuto Ngabonziza, Leen Rigouts, Tom Decroo, Eliane Kamanzi, Pauline Lempens, Aniceth Rucogoza, Yves Mucyo Habimana, Lies Laenen, Esdras Belamo Niyigena, Cécile Uwizeye, et al.
- Middlebrook 7h11 reduces invalid results and turnaround time of phenotypic drug‑susceptibility testing of M. tuberculosis(2022)
Authors: Rupasinghe Arachchige Praharshinie Rupasinghe, Jens Vereecken, Pieter Graulus, Tom Decroo, Elisa Ardizzoni, Cathy Hewison, Dimitri Donchuk, Helena Huerga, Anita Mesic, Leen Rigouts, et al.
Pages: 407-411 - Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings(2022)
Authors: Armand Van Deun, Valentin Bola, Rossin Lebeke, Michel Kayomo Kaswa, Mohamed Anwar Hossain, Mourad Gumusboga, Gabriela Torrea, Bouke de Jong, Leen Rigouts, Tom Decroo
- Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation(2022)
Authors: Mahamadou Bassirou Souleymane, Tom Decroo, Alphazazi Soumana, Ibrahim Maman Lawan, Assiatou Gagara-Issoufou, Souleymane Halidou-Moussa, Nimer Ortuno-Gutierrez, Eric Adehossi, Saidou Mamadou, Armand Van Deun, et al.
- Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study(2022)
Authors: Yves Habimana-Mucyo, Augustin Dushime, Patrick Migambi, Innocent Habiyambere, Jean Claude Semuto Ngabonziza, Tom Decroo
- Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018(2022)
Authors: Trudy Tholakele Mhlanga, Bart K Jacobs, Tom Decroo, Emma Govere, Hilda Bara, Prosper Chonzi, Ngwarai Sithole, Tsitsi Apollo, Wim Van Damme, Simbarashe Rusakaniko, et al.
- Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review(2022)
Authors: Jahan Saeed Mallick, Parvati Nair, Elizabeth Tabitha Abbew, Armand Van Deun, Tom Decroo
Pages: dlac029 - Community-based ART service delivery for key populations in sub-Saharan Africa: scoping review of outcomes along the continuum of HIV care(2022)
Authors: Olujuwon Justin Ibiloye, Caroline Masquillier, Plang Jwanle, Sara Van Belle, Josefien van Olmen, Lut Lynen, Tom Decroo
Pages: 2314-2337 - Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: a retrospective cohort study(2022)
Authors: Mahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, Alphazazi Soumana, Ibrahim Mamane Lawan, Assiatou Gagara-Issoufou, Eric Adehossi, Nimer Ortuno-Gutierrez, Lut Lynen, Leen Rigouts, et al.
Pages: 258–264 - Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study(2022)
Authors: Anita Mesic, Tobias Homan, Annick Lenglet, Phone Thit, Htay Thet Mar, Saw Myat Sabai, Moe Pyae Thandar, Thin Thin Thwe, Aung Aung Kyaw, Tom Decroo, et al.